{
  "id": 6104183,
  "title": "Claret Capital Partners exceeds target with €575M growth debt fund for European innovators",
  "url": "https://urgent.news/2026/09/07/claret-capital-partners-exceeds-target-with-575m-growth-debt-fund-for",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-07T06:00:00.000Z",
  "source": {
    "name": "Tech.eu",
    "slug": "tech-eu",
    "url": "https://tech.eu/2026/09/07/claret-capital-partners-exceeds-target-with-eur575m-growth-debt-fund-for-european-innovators/"
  },
  "original_language": "en",
  "account": "Claret Capital Partners has successfully closed its €575 million fourth European Growth Capital Fund, surpassing its initial €500 million objective. This fund targets technology, life sciences, and impact-focused companies across Europe, with 32% of its capital already deployed to back over 27 companies such as Billie, Cinclus Pharma, PRODA, Inventiva, and Surfe. The fund offers flexible, lower-dilution financing for companies seeking international expansion, acquisitions, and product development. Institutional investors, including pension funds, insurers, family offices, and public institutions, as well as private wealth investors through an ELTIF structure, contributed to the final close. Claret Capital Partners' Managing Partner, David Bateman, expressed that the fund's successful close exceeded expectations, reflecting ongoing support from limited partners and co-investors. The firm continues to identify promising high-quality opportunities and actively deploys capital. This development comes after Claret's previous €297 million fund, which closed in 2022 and has since seen exits like Cytora's acquisition by Applied Systems and Tiqets' acquisition by Expedia. The Managing Partner, Johan Kampe, anticipates increasing demand for flexible, non-dilutive capital as equity markets remain selective, and founders seek ways to scale without unnecessary dilution. Claret Capital Partners aims to expand its pan-European presence following the fund's successful closure, with team members now based in Paris and a planned presence in Berlin.",
  "summary": "Claret Capital Partners hasclosed its fourth European Growth Capital Fund at €575 million, exceeding its€500 million target. Including affiliated discretionary mandates, the fund willmake growth debt ...",
  "key_points": [
    "Claret Capital Partners closed €575M European Growth Capital Fund",
    "Fund targets tech, life sciences, impact companies across Europe",
    "32% of capital deployed to 27 companies including Billie and Cinclus Pharma"
  ],
  "editors_take": "Claret Capital Partners' oversized growth debt fund signals strong investor appetite for flexible, lower-dilution financing to back European innovators, particularly as equity markets remain selective and founders seek to scale.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}